Although there have been significant increases in the number of opioid-related overdose deaths in Black and Hispanic communities, the media narrative for this epidemic is often portrayed as a White, Non-Hispanic rural and suburban crisis. This article addressed culturally aligned policy considerations and treatment options for Black and Hispanic communities impacted by the opioid epidemic. Read more...

Co-authored by NIDA Director, Nora Volkow, MD, this research found those with SUDs are more vulnerable to COVID-19. Findings suggest providers develop action plans with their patients who have SUDs to prevent infection and/or complications from COVID-19. Read more...

Myths, disparities, and pervasive systemic inequities in health care have fostered bias and distorted perceptions of Black people’s pain, leading to catastrophic outcomes. This point of view article in NEJM identifies the urgent need for addressing inequities in pain care for Black patients. Read more...

"We now have a vital opportunity to advance the science in defining stability and success in methadone treatment, and to imagine and test ways in which telemedicine technology may facilitate OUD treatment." MACS Consultants, Drs. Aaron Greenblatt, Devang Gandhi, and Eric Weintraub, and Evaluator, Mimi Belcher, PhD, co-authored this commentary encouraging updates to opioid treatment programs following relaxed regulations. Read more...